Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engerix-B Kinder challenge dose study in adolescents previously vaccinated with Infanrix hexa
2013-002821-41Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by GSK. Primary endpoint: Primary: anti-HBs immune response after challenge dose. Started Oct 2013; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2013-002821-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002821-41.